Mannan-binding lectin (MBL) is an effector molecule of the innate immune system found in human serum that binds to carbohydrate and mediates recognition and killing of pathogens. Although the human immunodeficiency virus (HIV) would appear to be a good target of MBL due the unusually high level of high mannose glycosylation of gpl20, this has not been well studied. Our research - group found that MBL binds to a wide range of HIV isolates including primary isolates. Thus, MBL has several highly desirable features of an anti-HIV effector molecule; 1) it binds to a wide range of virus isolates; 2) binding of MBL to HIV is likely via the unusual cluster of high mannose microgram levels. These features of MBL suggest it mediates anti-viral activity in vivo and inforrnation gained about its interaction with HIV will lead to a better understanding of both the role of innate immunity during HIV infection and the importance of carbohydrate structures on HIV. The overall goals of this study are to determine the mechanism of interaction between MBL and HIV and to determine methods to enhance the anti-HIV activity of MBL. These goals will be accomplished by the following specific aims: Deterrnine the type and location of carbobydrates responsible for high-level binding of HIV- 1 to MBL. 2. Investigate factors that affect the interaction between HIV and MBL. 3. Utilize inhibitors of glycosylation to enhance biological effects of MBL. Exarnine the interaction of MBL with anti-viral antibodies in mediating anti-viral effects. Deterrnine the interaction of HIV-1 with MBL in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI046963-03
Application #
6532805
Study Section
Special Emphasis Panel (ZRG1-AARR-2 (01))
Program Officer
Voulgaropoulou, Frosso
Project Start
2000-08-01
Project End
2004-06-30
Budget Start
2002-08-01
Budget End
2003-06-30
Support Year
3
Fiscal Year
2002
Total Cost
$237,738
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kotton, Camille N; Lankowski, Alexander J; Scott, Nathaniel et al. (2006) Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine 24:6216-24
Ji, Xin; Gewurz, Henry; Spear, Gregory T (2005) Mannose binding lectin (MBL) and HIV. Mol Immunol 42:145-52
Ji, Xin; Olinger, Gene G; Aris, Sheena et al. (2005) Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol 86:2535-42
Ying, Hongyu; Ji, Xin; Hart, Melanie L et al. (2004) Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 20:327-35
Spear, Gregory T; Zariffard, M Reza; Xin, Ji et al. (2003) Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin. Immunology 110:80-5
Hart, Melanie L; Saifuddin, Mohammed; Spear, Gregory T (2003) Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. J Gen Virol 84:353-60
Olinger, Gene G; Saifuddin, Mohammed; Hart, Melanie L et al. (2002) Cellular factors influence the binding of HIV type 1 to cells. AIDS Res Hum Retroviruses 18:259-67
Hart, Melanie L; Saifuddin, Mohammed; Uemura, Kazuhide et al. (2002) High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retroviruses 18:1311-7
Siegal, F P; Spear, G T (2001) Innate immunity and HIV. AIDS 15 Suppl 5:S127-37
Spear, G T; Olinger, G G; Saifuddin, M et al. (2001) Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement. J Acquir Immune Defic Syndr 26:103-10